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Abstract
Background: The objective was to determine the repeatability and stability of capnography
interfaced with human exposure facility.
Methods: Capnographic wave signals were obtained from five healthy volunteers exposed to
particle-free, filtered air during two consecutive 5 min intervals, 10 min apart, within the open and
then the sealed and operational human exposure facility (HEF). Using a customized setup
comprised of the Oridion Microcap® portable capnograph, DA converter and AD card, the signal
was acquired and saved as an ASCII file for subsequent processing. The minute ventilation (VE),
respiratory rate (RR) and expiratory tidal volume (VTE) were recorded before and after
capnographic recording and then averaged. Each capnographic tracing was analyzed for acceptable
waves. From each recorded interval, 8 to 19 acceptable waves were selected and measured. The
following wave parameters were obtained: total length and length of phase II and III, slope of phase
II and III, area under the curve and area under phase III. In addition, we recorded signal measures
including the mean, standard deviation, mode, minimum, maximum – which equals end-tidal CO2
(EtCO2), zero-corrected maximum and true RMS.
Results:  Statistical analysis using a paired t-test for means showed no statistically significant
changes of any wave parameters and wave signal measures, corrected for RR and VTE, comparing
the measures when the HEF was open vs. sealed and operational. The coefficients of variation of
the zero-corrected and uncorrected EtCO2, phase II absolute difference, signal mean, standard
deviation and RMS were less than 10% despite a sub-atmospheric barometric pressure, and slightly
higher temperature and relative humidity within the HEF when operational.
Conclusion: We showed that a customized setup for the acquisition and processing of the
capnographic wave signal, interfaced with HEF was stable and repeatable. Thus, we expect that
analysis of capnographic waves in controlled human air pollution exposure studies is a feasible tool
for characterization of cardio-pulmonary effects of such exposures.
Published: 18 October 2006
BioMedical Engineering OnLine 2006, 5:54 doi:10.1186/1475-925X-5-54
Received: 02 May 2006
Accepted: 18 October 2006
This article is available from: http://www.biomedical-engineering-online.com/content/5/1/54
© 2006 Lukic et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BioMedical Engineering OnLine 2006, 5:54 http://www.biomedical-engineering-online.com/content/5/1/54
Page 2 of 11
(page number not for citation purposes)
Background
The primary objective of current and future air pollution
studies is to further understand the mechanisms for epide-
miologic data on increased morbidity and mortality due
to exposure to a ambient pollutants, e.g. fine particulate
air pollution, i.e. particles of aerodynamic diameter < 2.5
μm (PM2.5) [1-5]. In addition, the next objective is to link
the data from animal studies [6] with clinical evidence
related to adverse cardio-pulmonary and vascular events;
in particular, coronary and cerebro-vascular events related
with such exposure [7-10]. To this end, environmental air
pollution studies aim to reveal the physiologic changes
and molecular mechanisms that follow inhalation of gas-
eous and particulate pollution and lead to a systemic
inflammatory response. Moreover, they aim to provide
plausible explanations of the association between air pol-
lution exposure and morbidity/mortality from cardio-pul-
monary and vascular etiology. Understanding these
outcomes is of paramount importance in susceptible pop-
ulations such as children, the elderly, asthmatics, patients
suffering from chronic obstructive pulmonary disease
(COPD), cardiovascular diseases and diabetes.
Different health outcomes and indices have been assessed
during controlled human exposures to gaseous and partic-
ulate air pollution: ECG and lung function changes
[11,12], heart rate variability [13-15], blood and sputum
markers of inflammation – cellular variability and media-
tors including interleukin 6 (IL-6), leukotriene B4 (LTB4),
tumor necrosis factor alpha (TNFα,) interleukin 8 (IL-8),
endothelins and fibrinogen, [13,16].
Acute PM2.5 exposure can promote systemic inflammation
by activating the capillary endothelium in the pulmonary
circulation [17,18]. Therefore, we redirected our interests
in detecting acute effects of PM2.5 exposure from lung
mechanics to gas exchange surface of the alveolar-capil-
lary membrane. Our fine concentrated ambient particles
(CAP) exposure facility can concentrate particles sized
0.15 – 2.5 μm in aerodynamic diameter. Due to geometry
of the airways, fine particles (PM2.5) can be inhaled deep
into the small conducting bronchioles and the alveoli. If
adverse effects of PM2.5 are to be measured, a major site
that could be examined is the alveolar-capillary mem-
brane. Therefore, we considered capnography as the most
suitable procedure that can provide real-time information
about alveolar ventilation, pulmonary perfusion, respira-
tory pattern, and CO2 elimination/production. Clinically,
capnography has been used in concert with pulse oxyme-
try to detect adverse respiratory events during anesthesia
[19,20]. In addition, capnography has been used in emer-
gency rooms and during emergency transportation [21-
24]. However, although widely used in clinical and pre-
hospital settings, an extensive literature search confirmed
that capnography has not been used as a procedure or out-
come measure in settings of controlled human air pollu-
tion studies.
In our previous studies [17,25], we could not detect any
statistically significant changes in standard pulmonary
function measures, such as forced expiratory volume in
the 1st second (FEV1) or lung diffusing capacity for carbon
monoxide (DLCO). However, we have reported a constric-
tion of the brachial artery immediately following a 2-hour
CAP + O3 exposure [18] and an acute increase in diastolic
blood pressure in healthy adults during controlled expo-
sure to CAP ± O3 [26]. We hypothesize that "real-time"
capnography would be a more sensitive or even specific
marker of the inflammation induced by pollutants (CAP
± O3) at the alveolar-capillary membrane, as well as pol-
lutant-induced airway constriction, rather than more
gross, effort dependent functional tests such as spirometry
and lung diffusion. Since events at the alveolar-capillary
membrane are an instantaneous reflection of ventilatory/
cardiovascular function, any compromise of the ventila-
tion-perfusion relationship, which may result after
breathing CAP ± O3, could have some detectable conse-
quences. Therefore, capnography as a non-invasive,
instantaneous physiological measurement, which could
provide insight into alveolar ventilation, physiological
dead space changes, pulmonary perfusion, ventilation-
perfusion mismatch, changes of cardiac output and respi-
ratory patterns, seems to be a potentially valuable and
needed procedure in air pollution research.
In this study, we tested acquisition of the capnographic
wave signal for stability and repeatability through custom-
ized hardware & software components interfaced with the
human exposure facility of The Gage Occupational and
Environmental Health Unit, St. Michael's Hospital and
University of Toronto. The HEF design and exposure char-
acterization have been described in details elsewhere
[17,25]. See Figure 1 showing HEF with the door open.
Methods
Hardware and Software Setup
See Figure 2 for the schematic of the hardware interfaced
with the HEF, which was used for this procedure. In order
to record and analyze instantaneous CO2 digitized wave-
forms, we chose the commercially available Oridion
Microcap®  CO2  portable bedside capnograph (Oridion
Systems Ltd, Microcap®, model #CS-04178) [27]. It uses
Microstream® Technology with low-flow, sidestream aspi-
ration vs. traditional high-flow or mainstream monitors
[28,29]. This monitor has a low sampling rate of 50 ml/
min and an accuracy of EtCO2 readings of ± 2 mmHg in
the range of 0–38 mmHg and ± 5% of the reading in the
range of 39–99 mmHg, when steady state is reached.
EtCO2 accuracy is maintained for up to 80 breaths/min.
The system response time, including delay and rise time,BioMedical Engineering OnLine 2006, 5:54 http://www.biomedical-engineering-online.com/content/5/1/54
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is typically 2.45 seconds, with a maximum 2.9 seconds. In
addition, proprietary Microbeam IR source generates only
the specific wavelengths characteristic of the CO2 absorp-
tion spectrum. This IR source illuminates the microsam-
ple cell and reference channel, where the infrared
emission exactly matches the absorption spectrum of the
CO2 molecule, thus other gases in the sample such as
N2O, O2 and water vapor, do not affect the CO2 reading.
The capnograph has a built-in self-check procedure for
verification of validity of the recorded signal. These fea-
tures make it suitable for our HEF setting, in which we
expose non-intubated healthy subjects and subjects with
mild pulmonary or cardiovascular disease.
The capnograph we used, had a factory digital-output-
only, although, as an option the manufacturer provided a
Digital-to-Analog Converter (CS-07143) [30], which was
used to process out 4 digital signals including ground,
CO2 wave, respiratory rate and CO2 measurement validity
(indicates invalidity raising output voltage to full scale).
At full scale, 0.9 V equals 100 mmHg for the CO2 output
and 150 breaths/min for the respiratory rate output. A
voltage of 1.0 V indicates invalidity due to sampling line
disconnection, auto zero, and/or malfunction in all chan-
nels. An analog output from DA converter was directed to
the terminal board ADAM – 3968 SCSI 68P by Super Log-
ics Inc. and further by an expansion cable CS-G56 as a sin-
gle-ended connection to ADAC MF-5500, 12-bit, 100-kHz
PCI data acquisition board [31]. The CO2 wave signal res-
olution obtained through entire setup (capnograph, DA
converter and AD card) was 0.27874 mmHg over the full
scale of 100 mmHg. The acquired signal was captured by
WinView software v. 2.9 from Super Logic Inc [32], using
the continuous sampling mode with 20 samples per sec-
ond, board DMA and smooth scanning mode. Logged
data were saved as an ASCII file on the hard drive. The
The photo of HEF with door open Figure 1
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computer used was a Dell Optiplex GX270 with 3.2 GHz
Pentium 4 processor and 512 Mb RAM. Saved ASCII files
were imported into WinDaq Waveform Browser version
2.39 by DATAQ Instruments Inc. [33], where capno-
graphic waves were analyzed for acceptability according to
a Landis score [34]. Variables of interest were measured
and entered into an MS Access 2003 database.
The exhaled CO2  was sampled using two customized
Microstream®  EtCO2  adult NIV Lines™ [35], joined
together. We did not want to place the capnograph itself
within the sealed HEF, which is at sub-atmospheric pres-
sure (11 mmHg), and slightly higher temperature and rel-
ative humidity compared to laboratory and ambient
conditions, respectively. The first line (NIV-1) had the
capnograph end cut off and that end was attached inside
the HEF to the 20G diameter custom needle port, installed
through Plexiglas window. The subject used the patient
end as a nasal probe with prongs placed comfortably
within the nostrils. The second line (NIV-2) had the
patient end cut off and that end was attached to the other
side of the needle port. The capnograph end of this line
was attached to the sampling line port of the capnograph
itself. The total length of sampling line, joined in this fash-
ion, was 4.3 m.
Subjects
Two tests (EXP#1 and EXP#2) were carried out on five
healthy, non-smokers (4 males and 1 female), aged 35–
46. Continuous capnographic wave recordings were
obtained twice on each subject, 10 min apart, while seated
inside the HEF, first with the door open and then with the
door sealed under operational conditions. Subjects had
the sampling line nasal prongs placed inside their nostrils,
with a particle delivery/CO2 removal mask over their nose
and mouth. Monitoring and routine testing was carried
out as in our human exposure studies during a filtered air
control exposure [17,25]. One subject had variable and
Capnography components added to existing HEF design Figure 2
Capnography components added to existing HEF design. This illustration presents customized hardware & software 
components for the capnographic wave signal acquisition, interfaced with existing HEF used for the air pollution studies.BioMedical Engineering OnLine 2006, 5:54 http://www.biomedical-engineering-online.com/content/5/1/54
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completely unacceptable waveforms due to periodical
sniffling during the tests, thus we analyzed data for four
subjects. Immediately before and after each capnographic
waveform recording, resting expired tidal volume and res-
piratory rate were measured using a VMM-401 flow tur-
bine by Interface Associates [37]. It was essential to
directly measure tidal volume and respiratory rate, as
changes in these parameters can modify the EtCO2 [38].
The protocol was approved by the Research Ethics Board
of St. Michael's Hospital, Toronto.
Data and Statistical Analysis
We measured acceptable capnographic waves for two sets
of variables (wave parameters and wave statistics) and two
ventilatory variables, shown in Table 1. Selected capno-
graphic wave parameters are described in the literature
with defined physiologic meaning and with the ability to
characterize certain ventilatory changes [34,39,40]. Cap-
nographic wave signal statistics represented standard sta-
tistical parameters, noting that RMS is derived as true RMS
by means of an appropriate algorithm within WINDAQ
software, and in this case represented mean expired CO2
(expressed in mmHg) over the expiratory phase of one
breath. The mathematical definition of true RMS used by
WINDAQ to derive this statistics is   where:
vn = instantaneous voltage and W = window size [41].
Measurements such as mean blood pressure and/or flow
from a pulsatile pressure, airflow waveform and of course
capnographic wave are non-sinusoidal waveforms that
require a true RMS calculation. Breathing pattern, low res-
piratory rate and large tidal volume, can influence the
shape of the capnographic wave, particularly the slope of
phase III of the capnographic wave [42]; therefore, we
recorded these parameters for the purpose of the quality
control of the recorded capnographic wave parameters
and statistics during the two tests. See Figure 3 showing
the example of typical capnographic wave analysis, using
WinDaq software.
From the list of variables in Table 1, we selected 18 varia-
bles for statistical analyses. Nine describe aspects of the
entire waveform and include the variables: tot_len,
tot_AUC, EtCO2, CORRMAX, MIN, MEAN, STDEV, MED
and RMS. Three describe phase II, from the start of the
wave upstroke to the beginning of the alveolar plateau,
and include len2, slope2 and absolute difference for
slope2. Four describe phase III, the start to the end of the
alveolar plateau, and include len3, slope3, diff3 and
AUC3. Two were obtained from the minute ventilation
test, immediately before and after the capnography test,
reported as an average value, and include average RR and
average VTE. Means, standard deviations, coefficients of
variation (CV) and the number (N) of waveforms for each
subject's test (in total EXP #1 = 60 waves and EXP #2 = 54
waves) were calculated for each of the 18 variables. The
prefix M1 and M2 are the means for tests #1 and #2, S1
and S2 are the standard deviations and CV1 and CV2 the
coefficients of variation (100 × standard deviation/mean).
Data are reported for the four subjects, each of whom had
two 5-minute capnography tests (8 tests in total). Among
the 8 tests, the number of waveforms ranged from 8–19,
depending on the subject's respiratory rate and acceptabil-
ity of waveforms. Statistical analysis was performed using
the SAS System for Windows v. 8.2 (SAS Institute Inc.,
Cary, NC., USA). The differences between the wave
parameters, ventilatory parameters and signal statistics
obtained within the open (EXP#1) and sealed (EXP#2)
HEF, were evaluated using a paired t-test. A p-value < 0.05
was considered to indicate a statistically significant differ-
ence.
Results
The results of the measurements for monitored variables
are presented in Tables 2, 3, and 4. Summary data for
EtCO2 parameters, comparing EXP#1 and EXP#2 for the
four subjects are shown in Table 2. The two variables with
the lowest CV were zero-corrected EtCO2 (CORRMAX),
3.89% for the first and 3.62% for the second measure-
ment, and EtCO2 4.14% for the first and 4.48% for the
second measurement, respectively. The phase II absolute
difference (diff2) had a slightly higher CV, 6.48% and
6.52%. The eight other variables all had maximum CVs
>10%, with the highest CV for the phase III slope
(slope3), 52.57% and 57.96%. None of the mean values
for these parameters measured with the HEF open and
sealed showed any significant statistical difference. The p-
values ranged from 0.16 for diff3 (phase III absolute dif-
ference) to 0.98 for len2 (length of the phase II).
Summary data for the ventilatory parameters, VTE and RR
comparing EXP#1 and EXP#2 for the four subjects are
shown in Table 3. The coefficients of variation for these
two variables were above 10%, 21.87% for the CV of RR
for the first measurement and 33.25% for CV of VTE for
the second measurement. In addition, none of the mean
values for these parameters was significantly different
comparing the open versus sealed and operational HEF.
Descriptive statistics for EtCO2 signal variables measured
within the open and sealed HEF (EXP#1 and EXP#2) are
presented in Table 4. The coefficient of variation for RMS
is smaller than the CV for MEAN, for both exposures,
while the EtCO2 signal zero (MINIMUM) has the highest
CV of all variables. The paired t-test for means showed no
νn n
W
W
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2
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significant statistical difference between measurements
within open and sealed HEF for any of these variables.
Discussion
We added customized hardware and software compo-
nents to interface with the HEF in order to utilize the
advantages of capnography over the standard tests of lung
function. We chose to use capnography in the HEF as we
expect that capnography will be a useful tool for the detec-
tion of changes in ventilation during human exposure
studies. Capnography, as a non-invasive, real-time physi-
ologic measurement of adequacy of ventilation and per-
fusion, has found its role in a variety of medical
disciplines including anesthesiology, critical care, emer-
gency medicine, cardiology, pediatrics, neurology and res-
piratory care. Current capnographic hardware and
software is designed for these aforementioned environ-
ments. As such, we did not find a commercially available,
ready-to-go solution for the implementation of capnogra-
phy in the experimental environment of human air pollu-
tion exposure studies. Our goal was to use relatively
inexpensive and commercially available hardware com-
ponents to acquire EtCO2 wave signals within sealed and
operational HEF, but with acceptable signal quality. Our
first choice for the capnograph was the Microcap® CO2
portable bedside monitor, with nominal performance fea-
tures adequate for our study's setup. However, due to the
absence of an analog output, this monitor needed an
additional digital-to-analog converter. We used one sup-
plied as an option by the original manufacturer, designed
to be used with this particular model of capnograph. Fur-
ther processing of the four analog signals (EtCO2 wave,
RR, EtCO2 wave signal validity and ground) utilized the
standard solution (terminal board, expansion cable and
MF 5500 AD card). Although the signal was less than 1.0
V, due to the low level of noise, we found that a single
ended connection was adequate. We performed zero CO2
calibration of the capnograph with 100% O2, in order to
measure the system signal noise for the overall hardware
and software setup. The average noise level was 0.0052 ±
0.016 V and RMS was 0.0168 V. Signal-to-noise ratio
(SNR) over the full scale of 100 mmHg was 34.59 dB. We
found the WinView data acquisition software easy to
install and setup using the MF 5500 AD board. The EtCO2
Table 1: Monitored variables during two 5 min tests within the open and sealed HEF
Variable Label
Identification and class variable
ID Subject ID #
EXP Test number (1-first or 2-second)
EtCO2 wave parameters
POINTS Number of CO2 measurements (20 samples/second) per one respiratory cycle
tot_len Total time from STARTPOINT to ENDPOINT (seconds)
tot_AUC Cross sectional area under the curve depicting detectable CO2 (mm Hg X seconds)
len2 Time from STARTPOINT to start of alveolar plateau (seconds)
slope2 Slope from STARTPOINT to start of alveolar plateau (mm Hg/second)
diff2 CO2 absolute change from STARTPOINT to start of alveolar plateau (mm Hg)
len3 Time from start to end of alveolar plateau (seconds)
slope3 Slope from start to end of alveolar plateau (mm Hg/second)
diff3 CO2 absolute change from start to end of alveolar plateau (mm Hg)
EtCO2 End tidal CO2 (maximum expired CO2 (mm Hg)
AUC3 Cross sectional area under the alveolar plateau (mm Hg X seconds)
EtCO2 Wave Signal Statistics
MIN Minimum (lowest) CO2 value from STARTPOINT to ENDPOINT
MAX Maximum (highest) CO2 value from STARTPOINT to ENDPOINT
CORRMAX Maximum (highest) CO2 value corrected for minimum (zero) value
MEAN Mean CO2 value from STARTPOINT to ENDPOINT
MED Median CO2 value from STARTPOINT to ENDPOINT
STDEV Standard deviation of mean CO2 value from STARTPOINT to ENDPOINT
RMS (true) Root mean square of CO2 values from STARTPOINT to ENDPOINT
Minute Ventilation Variables
RR Average respiratory rate (breaths/minute)
VTE Average expiratory tidal volume (liters/BTPS)BioMedical Engineering OnLine 2006, 5:54 http://www.biomedical-engineering-online.com/content/5/1/54
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wave signal was saved as an ASCII file and imported into
WinDaq Waveform Browser. This software was quite ade-
quate for EtCO2 wave signal analysis.
An additional concern, related to the EtCO2 sampling line
required a customized solution. We used two original
sampling lines to make one custom line, which attaches
on both sides of the custom-made needle port screwed
into the plexiglas HEF window. Accordingly, we did not
observe additional delay added to frequency response of
the monitor. We considered the possibility that sampling
through a longer line than originally designed and recom-
mended by the manufacturer could also affect the per-
formance of the capnography monitor. However, we did
not observe that sampling in this way affected the reading
of EtCO2 and RR on the capnograph itself. Mason et al.
[36] showed that an experimental sampling line as long as
The example of capnographic wave analysis using WinDaq software Figure 3
The example of capnographic wave analysis using WinDaq software. Screenshot of WinDaq windows showing the 
measurement of slope3 of the typical capnographic wave.BioMedical Engineering OnLine 2006, 5:54 http://www.biomedical-engineering-online.com/content/5/1/54
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9.0 m was equally reliable as the standard 3.0 m long one,
which agrees with our observation.
Comparisons of the differences between capnographic
measurements obtained under two different conditions,
relevant to our design of human exposure studies (open
and sealed HEF), did not yield any statistical significance.
Yet, some differences existed in absolute values, but allo-
cation of these differences among observed measures was
to be expected. In the group of EtCO2 wave parameters,
the variable with the lowest CV was the zero-corrected
EtCO2, 3.89% and 3.62%, followed closely by EtCO2,
4.14% and 4.48%. Verschuren et al. [43] considered CV of
the EtCO2 less than 5% as an indicator of steady-state sta-
tus for their patients The EtCO2 is the main output value
of the capnograph and correction of this value with the
minimum-recorded value, for a particular wave, increased
the accuracy of true EtCO2 reading. Among seven out of
eight tests, we found that the range of recorded zero values
for EtCO2 was between 0 and 0.55664 mmHg (1.42% of
maximum-recorded EtCO2 of 39.167 mmHg). Surpris-
ingly, we found that one subject's exposure (EXP#2 for
that subject, with 15 acceptable analyzed waves) had
recorded a zero range between 1.4274 to 2.8547 mmHg
(7.29% of the maximum-recorded EtCO2  of 39.167
mmHg). Reviewing the lab log for this test, we found that
5 min after the enclosure was sealed, the recorded CO2
within the HEF was approximately 0.38%. This could
have happened, because the particle delivery/CO2
removal mask either was not in place or correctly posi-
tioned, or in the case of the CO2 removal pump system
malfunction. Thus, the maximum recoded zero for EtCO2
was approximately the background concentration of CO2
in the sealed HEF (749 mmHg × 0.0038 = 2.846 mmHg).
Later, we were able to simulate this pattern of zero shift
with the particle delivery/CO2 removal mask incorrectly
positioned and this explained the unexpected CV of the
MINIMUM variable for the EtCO2 signal. See Figure 4 for
the EtCO2 tracing of that original test in trend format.
CV for the slopes of phase II and III, for both measure-
ments, showed that these two variables are also the ones
with the largest physiologic variability even in the steady
state. Thus, they have the potential to be considered as
Table 3: Descriptive statistics for ventilatory parameters by exposure within open and sealed HEF and the paired t-test for ventilatory 
parameters
Ventilatory Parameters EXP Paired t-test (exp1-exp2)
12
N Mean Std CV N Mean Std CV t p
VTE 60 0.59 0.15 24.68 54 0.61 0.20 33.25 -0.33 0.76
RR 60 15.3 3.35 21.87 54 14.65 4.19 28.63 1.10 0.35
Table 2: Descriptive statistics for capnographic wave parameters by exposure within open and sealed HEF and the paired t-test for 
EtCO2 wave parameters
EtCO2 Wave Parameters EXP Paired t-test (exp1-exp2)
12
N Mean Std CV N Mean Std CV t p
Total length 60 3.53 0.63 17.9 54 3.39 0.69 20.32 0.62 0.58
Total area under the curve 60 84.62 16.85 19.92 54 78.68 16.89 21.46 0.85 0.46
phase II length 60 0.76 0.19 24.44 54 0.73 0.2 27.58 -0.02 0.98
phase II slope 60 44.46 10.19 22.92 54 45.41 10.38 22.86 0.49 0.66
phase II absolute difference 60 31.97 2.07 6.48 54 31.28 2.04 6.52 1.03 0.38
phase III length 60 1.63 0.39 24.02 54 1.52 0.41 26.96 0.81 0.48
phase III slope 60 3.15 1.66 52.57 54 3.49 2.02 57.96 -1.33 0.28
phase III area under the curve 60 59.40 13.44 22.63 54 54.86 14.36 26.18 0.64 0.57
phase III absolute difference 60 4.58 1.61 35.23 54 4.26 1.63 38.16 1.85 0.16
EtCO2 (signal maximum) 60 37.12 1.54 4.14 54 36.53 1.63 4.48 0.95 0.41
Zero-corrected EtCO2 60 36.84 1.43 3.89 54 35.83 1.3 3.62 1.29 0.29BioMedical Engineering OnLine 2006, 5:54 http://www.biomedical-engineering-online.com/content/5/1/54
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variables capable of detecting a deviation from the normal
pattern as well. Changes in RR, VTE, and ventilation mald-
istribution expressed as ventilation/perfusion (V/Q) mis-
match, can result in changes of phase II and III of the
EtCO2 wave [42]. For both, EXP#1 and EXP#2, RR and VTE
were virtually identical, allowing us to have slopes of
phase II and III clearly comparable between the two meas-
urements. The CV for RR and VTE (range 21.87 to 33.25)
were somewhat higher than reported by Verschuren at al.
[43] for their patients. We believe that this might be pos-
Unexpected zero shift for one test out of eight Figure 4
Unexpected zero shift for one test out of eight. Screenshot of WinDaq window showing trend capnography tracing for 
the EXP#1 (left side) and EXP#2 (right side) for the subject who had the particle delivery/CO2 removal mask incorrectly posi-
tioned during the EXP#2 that caused CO2 re-breathing.
Table 4: Descriptive statistics for EtCO2 wave signal parameters by exposure within open and sealed HEF and paired t-test for EtCO2 
signal parameters
EtCO2 Wave Signal Statistics EXP Paired t-test (exp1-exp2)
12
N Mean Std CV N Mean Std CV t p|
MEAN 60 23.73 2.25 9.47 54 22.86 1.60 7.01 1.21 0.31
STDEV 60 13.85 1.14 8.21 54 13.81 0.69 5.01 0.16 0.88
MINIMUM 60 0.31 0.22 72.02 54 0.78 0.86 110.16 1.04 0.37
MEDIAN 60 30.60 3.81 12.47 54 29.55 3.59 12.15 0.59 0.60
RMS 60 27.49 1.75 6.37 54 26.67 1.45 5.43 1.21 0.31BioMedical Engineering OnLine 2006, 5:54 http://www.biomedical-engineering-online.com/content/5/1/54
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sibly due to the psychological effect of the limited space in
the HEF, which might affect the variability of the breath-
ing pattern.
In the group of EtCO2 signal variables, we found that the
CV for RMS was smaller than for the MEAN, because RMS
has been calculated as the true RMS and better represents
the "average" value of expired CO2 than the MEAN value
obtained by the standard equation. The true RMS, in this
case, better approximates mixed-expired CO2 (PECO2) per
one breath or over the time that the EtCO2 signal was
"averaged". The PECO2 and arterial partial pressure for
CO2 (PaCO2) are used to calculate dead space to tidal vol-
ume ratio (VD/VT).
Conclusion
We have described a customized, inexpensive and feasible
hardware and software implementation of standard cap-
nography, as an adjunct to our human exposure facility,
which is used in air pollution studies. Our hardware and
software setup for acquisition and analysis of EtCO2 wave
signal was demonstrated as reliable and stable. We would
have preferred that the selected capnograph monitor have
an analog output, so we could avoid digital to analog sig-
nal conversion. The instrument was meant to be used in
standard pre-hospital or hospital environments, therefore
the manufacturer had not considered that option. How-
ever, extending the use of capnography into research labs
like ours, where we carry out air pollution human expo-
sure studies, has been long overlooked. Using capnogra-
phy in the way we described, we may be able to detect and
better characterize the effect of exposure to air pollution
on cardiopulmonary system, particularly on lung ventila-
tion and perfusion. We plan to use this technique in our
on-going and subsequent controlled human exposure
studies as a physiologic outcome measure.
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